Cargando…
The Progress of Chitosan-Based Nanoparticles for Intravesical Bladder Cancer Treatment
Bladder cancer (BC) is the most frequently occurring cancer of the urinary system, with non-muscle-invasive bladder cancer (NMIBC) accounting for 75–85% of all the bladder cancers. Patients with NMIBC have a good survival rate but are at high risk for tumor recurrence and disease progression. Intrav...
Autores principales: | Yu, Chong, Wang, Shuai, Lai, Wing-Fu, Zhang, Dahong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861699/ https://www.ncbi.nlm.nih.gov/pubmed/36678840 http://dx.doi.org/10.3390/pharmaceutics15010211 |
Ejemplares similares
-
The Use of Polymer Chitosan in Intravesical Treatment of Urinary Bladder Cancer and Infections
por: Erman, Andreja, et al.
Publicado: (2018) -
Intravesical Treatments of Bladder Cancer: Review
por: Shen, Zancong, et al.
Publicado: (2008) -
Intravesical Agents in the Treatment of Bladder Clots in Children
por: Della Corte, Marcello, et al.
Publicado: (2023) -
Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancer
por: Smith, Sean G., et al.
Publicado: (2016) -
Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression
por: Delto, Joan C., et al.
Publicado: (2013)